Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG (FMS) is a healthcare company (medical care facilities) based in Germany. The share price is $21.85, down 0.05% on the day, which values the company at $11.34B. Price as of 17 Nov 2026, 17:13 UTC, from Yahoo Finance.
Key facts
- Share price
- $21.85−0.05% today
- Market value
- $11.34B
- P/E ratio
- 12.6×last 12 months
- Forward P/E
- 8.3×
- Dividend yield
- 6.82%
- Funk Score
- 45/100
- 200-week average
- $22.583% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Fresenius Medical Care AG in more detail
FMS trades at 12.6× its last twelve months' earnings, 8.3× next year's expected earnings, 0.6× sales. It sits 3% below its 200-week average of $22.58.
Its Funk Score is 45 out of 100 (financial strength 4.4, profitability 5.1, growth 4.1, each out of 10).
In its favour: Strong Piotroski score.
3 of the superinvestors tracked here hold FMS, including Richard Pzena (1.1% of the portfolio), Charles Brandes (founder) (0.3% of the portfolio), Dodge & Cox team (0.0% of the portfolio).
Superinvestors holding FMS
3 of the investors tracked here report a position in their latest 13F filing.
- Richard Pzena Pzena Investment Management1.09% of portfolio · $371.9M · added · Q3 2026
- Charles Brandes (founder) Brandes Investment Partners0.30% of portfolio · $44.1M · added · Q3 2026
- Dodge & Cox team Dodge & Cox0.04% of portfolio · $74.5M · trimmed · Q3 2026
Health Care companies of similar size
- Smith & NephewSNN
- PenumbraPEN
- Dr. Reddy's LaboratoriesRDY
- Align TechnologyALGN
- Cooper CompaniesCOO
- Kymera TherapeuticsKYMR
- DaVitaDVA
- Halozyme TherapeuticsHALO
- Universal Health ServicesUHS
- RepligenRGEN
- Bio-TechneTECH
- BioMarin PharmaceuticalBMRN
Side by side:FMS vs KYMR (Fresenius Medical Care AG vs Kymera Therapeutics)FMS vs DVA (Fresenius Medical Care AG vs DaVita)FMS vs HALO (Fresenius Medical Care AG vs Halozyme Therapeutics)FMS vs UHS (Fresenius Medical Care AG vs Universal Health Services)FMS vs COO (Fresenius Medical Care AG vs Cooper Companies)
All health care companies by market valueLargest companies in GermanyAll stocks A–Z
Fresenius Medical Care AG (FMS): questions and answers
What is FMS's P/E ratio?
Fresenius Medical Care AG trades at 12.6× its last twelve months' earnings and 8.3× next year's expected earnings.
What is FMS's PEG ratio?
Fresenius Medical Care AG's PEG ratio is 0.96 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Fresenius Medical Care AG's market cap?
Fresenius Medical Care AG is valued at $11.34B at a share price of $21.85.
Is FMS above its 200-week moving average?
No. FMS is 3.2% below its 200-week average of $22.58. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Fresenius Medical Care AG growing?
Over the last three fiscal years Fresenius Medical Care AG's revenue grew 0.4% a year and its earnings per share 13.5% a year.
Does FMS pay a dividend?
Yes. Fresenius Medical Care AG's dividend yield is 6.82%, or $0.87 a share a year, paying out 50% of earnings.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Fresenius Medical Care AG (FMS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/FMS
Underlying data: Yahoo Finance; company filings with the SEC.